The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology
Open accessAbstract
Small bowel adenocarcinoma (SBA) is a rare malignancy of the gastrointestinal tract that has increased in incidence across recent years. Often diagnosed at an advanced stage, outcomes for SBA are worse on average than for other related malignancies, including colorectal cancer. Due to the rarity of this disease, few studies have been done to direct optimal treatment, although recent data have shown that SBA responds to treatment differently than colorectal cancer, necessitating a separate approach to treatment. The NCCN Guidelines for Small Bowel Adenocarcinoma were created to establish an evidence-based standard of care for patients with SBA. These guidelines provide recommendations on the workup of suspected SBA, primary treatment options, adjuvant treatment, surveillance, and systemic therapy for metastatic disease. Additionally, principles of imaging and endoscopy, pathologic review, surgery, radiation therapy, and survivorship are described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,781
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Overman, M. J., McDermott, R., Leach, J. L., Lonardi, S., Lenz, H.-J., Morse, M. A., Desai, J., Hill, A., Axelson, M., Moss, R. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30422-9 · Cited by 2,836
Self-citationEfficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
Drilon, A., Laetsch, T. W., Kummar, S., DuBois, S. G., Lassen, U. N., Demetri, G. D., Nathenson, M., Doebele, R. C., Farago, A. F., Pappo, A. S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714448 · Cited by 2,824
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Overman, M. J., Lonardi, S., Wong, K. Y. M., Lenz, H.-J., Gelsomino, F., Aglietta, M., Morse, M. A., Van Cutsem, E., McDermott, R., Hill, A., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.9901 · Cited by 2,079
Self-citationMolecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,656
Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623
Very high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,445
Prognostic Factors in Prostate Cancer: College of American Pathologists Consensus Statement 1999
Bostwick, D. G., Grignon, D. J., Hammond, M. E. H., Amin, M. B., Cohen, M., Crawford, D., Gospadarowicz, M., Kaplan, R. S., Miller, D. S., Montironi, R., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0995-pfipc · Cited by 1,239
Prognostic Factors in Colorectal Cancer: College of American Pathologists Consensus Statement 1999
Compton, C. C., Fielding, L. P., Burgart, L. J., Conley, B., Cooper, H. S., Hamilton, S. R., Hammond, M. E. H., Henson, D. E., Hutter, R. V. P., Nagle, R. B., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0979-pficc · Cited by 1,230
Self-citationPeutz-Jeghers syndrome is caused by mutations in a novel serine threoninekinase
Jenne, D. E., Reomann, H., Nezu, J.-I., Friedel, W., Loff., S., Jeschke, R., Müller, O., Back, W., & Zimmer, M. (1998) · Nature Genetics · doi:10.1038/ng0198-38 · Cited by 1,205
Duration of adjuvant chemotherapy for stage III colon cancer
Grothey, A., Sobrero, A. F., Shields, A. F., Yoshino, T., Paul, J., Taieb, J., Souglakos, J., Shi, Q., Kerr, R., Labianca, R., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1713709 · Cited by 1,092
Self-citationFrequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome
Hearle, N., Schumacher, V., Menko, F. H., Olschwang, S., Boardman, L. A., Gille, J. J. P., Keller, J. J., Westerman, A. M., Scott, R. J., Lim, W., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0083 · Cited by 855
Vasen, H., Wijnen, J., Menko, F., Kleibeuker, J., Taal, B., Griffioen, G., Nagengast, F., Meijers-Heijboer, E., Bertario, L., Varesco, L., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8612988 · Cited by 816
Familial adenomatous polyposis
Galiatsatos, P., & Foulkes, W. D. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00375.x · Cited by 757
(2006) · National Academies Press eBooks · doi:10.17226/11613 · Cited by 737
Bilimoria, K. Y., Bentrem, D. J., Wayne, J. D., Ko, C. Y., Bennett, C. L., & Talamonti, M. S. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e31818e4641 · Cited by 683
Hutchins, G., Southward, K., Handley, K., Magill, L., Beaumont, C., Stahlschmidt, J., Richman, S., Chambers, P., Seymour, M., Kerr, D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1366 · Cited by 681
Familial adenomatous polyposis
Half, E., Bercovich, D., & Rozen, P. (2009) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-4-22 · Cited by 596
PD-1 blockade in tumors with mismatch repair deficiency.
Le, D. T., Uram, J. N., Wang, H., Bartlett, B., Kemberling, H., Eyring, A., Skora, A., Azad, N. S., Laheru, D. A., Donehower, R. C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.33.15_suppl.lba100 · Cited by 565
High Cancer Risk in Peutz–Jeghers Syndrome: A Systematic Review and Surveillance Recommendations
van Lier, M. G. F., Wagner, A., Mathus-Vliegen, E. M. H., Kuipers, E. J., Steyerberg, E. W., & van Leerdam, M. E. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.725 · Cited by 542
Adenocarcinoma of the small bowel: Presentation, prognostic factors, and outcome of 217 patients
Dabaja, B. S., Suki, D., Pro, B., Bonnen, M., & Ajani, J. (2004) · Cancer · doi:10.1002/cncr.20404 · Cited by 535
Perineural Invasion Is an Independent Predictor of Outcome in Colorectal Cancer
Liebig, C., Ayala, G., Wilks, J., Verstovsek, G., Liu, H., Agarwal, N., Berger, D. H., & Albo, D. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.4949 · Cited by 521
Adam, R., Chiche, L., Aloia, T., Elias, D., Salmon, R., Rivoire, M., Jaeck, D., Saric, J., Treut, Y. P. L., Belghiti, J., et al. (2006) · Transactions of the ... Meeting of the American Surgical Association · doi:10.1097/01.sla.0000239036.46827.5f · Cited by 411
Mols, F., Beijers, T., Lemmens, V., van den Hurk, C. J., Vreugdenhil, G., & van de Poll-Franse, L. V. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.1514 · Cited by 359
Kim, G. P., Colangelo, L. H., Wieand, H. S., Paik, S., Kirsch, I. R., Wolmark, N., & Allegra, C. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.8172 · Cited by 342
Tomlinson, I. P., & Houlston, R. S. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.12.1007 · Cited by 335
The Challenges of Colorectal Cancer Survivorship
Denlinger, C. S., & Barsevick, A. M. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0058 · Cited by 324
Klingbiel, D., Saridaki, Z., Roth, A. D., Bosman, F. T., Delorenzi, M., & Tejpar, S. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu499 · Cited by 231
Genomic Profiling of Small-Bowel Adenocarcinoma
Schrock, A. B., Devoe, C. E., McWilliams, R., Sun, J., Aparicio, T., Stephens, P. J., Ross, J. S., Wilson, R., Miller, V. A., Ali, S. M., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.1051 · Cited by 227
Self-citationBeamer, L. C., Grant, M. L., Espenschied, C. R., Blazer, K. R., Hampel, H. L., Weitzel, J. N., & MacDonald, D. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.4719 · Cited by 202
Intestinal Cancer Risk in Crohn’s Disease: A Meta-Analysis
Laukoetter, M. G., Mennigen, R., Hannig, C. M., Osada, N., Rijcken, E., Vowinkel, T., Krieglstein, C. F., Senninger, N., Anthoni, C., & Bruewer, M. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1402-9 · Cited by 196
Bailey, A. A., Debinski, H. S., Appleyard, M. N., Remedios, M. L., Hooper, J. E., Walsh, A. J., & Selby, W. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00749.x · Cited by 190
Bertagnolli, M. M., Redston, M., Compton, C. C., Niedzwiecki, D., Mayer, R. J., Goldberg, R. M., Colacchio, T. A., Saltz, L. B., & Warren, R. S. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0092 · Cited by 188
Self-citationHendriks, Y. M. C., de Jong, A. E., Morreau, H., Tops, C. M. J., Vasen, H. F., Wijnen, J. T., Breuning, M. H., & Brocker-Vriends, A. H. J. T. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.4.213 · Cited by 178
Further observations on LKB1/STK11 status and cancer risk in Peutz–Jeghers syndrome
Lim, W., Hearle, N., Shah, B., Murday, V, Hodgson, S. V., Lucassen, A., Eccles, D., Talbot, I., Neale, K., Lim, A. G., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601030 · Cited by 176
Small bowel adenocarcinomas—existing evidence and evolving paradigms
Raghav, K., & Overman, M. J. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.132 · Cited by 172
Self-citationOverman, M. J., Hu, C.-Y., Kopetz, S., Abbruzzese, J. L., Wolff, R. A., & Chang, G. J. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2173-6 · Cited by 172
Self-citationJansen, L., Herrmann, A., Stegmaier, C., Singer, S., Brenner, H., & Arndt, V. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.4013 · Cited by 170
FDA grants accelerated approval to pembrolizumab for first tissue/site agnostic indication
Administration, U. S. F. &. D. (2017) · Case Medical Research · doi:10.31525/fda1-ucm560040.htm · Cited by 158
Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study
Zaanan, A., Costes, L., Gauthier, M., Malka, D., Locher, C., Mitry, E., Tougeron, D., Lecomte, T., Gornet, J., Sobhani, I., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq038 · Cited by 157
Sunada, K. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i7.1087 · Cited by 132
Describing and predicting psychological distress after colorectal cancer
Lynch, B. M., Steginga, S. K., Hawkes, A. L., Pakenham, K. I., & Dunn, J. C. (2008) · Cancer · doi:10.1002/cncr.23300 · Cited by 131
Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study
Aparicio, T., Svrcek, M., Zaanan, A., Beohou, E., Laforest, A., Afchain, P., Mitry, E., Taïeb, J., Fiore, F. D., Gornet, J., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.677 · Cited by 125
Ecker, B. L., McMillan, M. T., Datta, J., Mamtani, R., Giantonio, B. J., Dempsey, D. T., Fraker, D. L., Drebin, J. A., Karakousis, G. C., & Roses, R. E. (2015) · Cancer · doi:10.1002/cncr.29840 · Cited by 122
Sonography of the small intestine
Nylund, K., Ødegaard, S., Hausken, T., Folvik, G., Lied, G. A., Viola, I., Hauser, H., & Gilja, O. H. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1319 · Cited by 118
[A serine/threonine kinase gene defective in Peutz-Jeghers syndrome].
Hemminki, A., Avizienyte, E., Roth, S., Loukola, A., Aaltonen, L. A., Järvinen, H., & de la Chapelle, A. (1998) · PubMed · Cited by 116
Xiao, X., Liu, Y. W., Zhang, L., Qiu, F., Feng, Y. Y., Zhan, Z. Y., Feng, M., Yan, J., Zhao, J. G., & Xiong, J. P. (2012) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328350dd0d · Cited by 115
ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma
Laforest, A., Aparicio, T., Zaanan, A., Pittella-Silva, F., Didelot, A., Desbeaux, A., Corre, D. L., Benhaïm, L., Pallier, K., Aust, D. E., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.04.007 · Cited by 105
Thong, M. S. Y., Mols, F., Wang, X. S., Lemmens, V. E. P. P., Smilde, T. J., & van de Poll-Franse, L. V. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.01.012 · Cited by 99
Sakae, H., Kanzaki, H., Nasu, J., Akimoto, Y., Matsueda, K., Yoshioka, M., Nakagawa, M. M., Hori, S., Inoue, M., Inaba, T., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.338 · Cited by 97
Zaanan, A., Gauthier, M., Malka, D., Locher, C., Gornet, J., Thirot‐Bidault, A., Tougeron, D., Taïeb, J., Bonnetain, F., & Aparicio, T. (2010) · Cancer · doi:10.1002/cncr.25614 · Cited by 90
Population-Based Molecular Screening for Lynch Syndrome: Implications for Personalized Medicine
Ward, R. L., Hicks, S. C., & Hawkins, N. J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.8454 · Cited by 89
Utility of positron emission tomography/CT in the evaluation of small bowel pathology
Cronin, C. G., Scott, J. A., Kambadakone, A. R., Catalano, O. A., Sahani, D. V., Blake, M. A., & McDermott, S. (2012) · British Journal of Radiology · doi:10.1259/bjr/64534573 · Cited by 74
Tsushima, T., Taguri, M., Honma, Y., Takahashi, H. E., Ueda, S., Nishina, T., Kawai, H., Kato, S., Suenaga, M., Fumio, T., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0079 · Cited by 72
Oh, S. Y., Edwards, A. M., Mandelson, M. T., Ross, A. S., Irani, S. S., Larsen, M. C., Gan, S. I., Glück, M., Picozzi, V. J., Helton, S. W., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.01.026 · Cited by 71
Postgate, A., Hyer, W., Phillips, R. K. S., Gupta, A., Burling, D. N., Bartram, C. I., Marshall, M. B., Taylor, S. A., Brown, G. J., Schofield, G., et al. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31818f0a1f · Cited by 69
Familial Adenomatous Polyposis
Church, J. M. (2009) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2009.07.002 · Cited by 66
Gulhati, P., Raghav, K. P. S., Shroff, R. T., Varadhachary, G. R., Kopetz, S., Javle, M. M., Qiao, W., Wang, H., Morris, J. S., Wolff, R. A., et al. (2016) · Cancer · doi:10.1002/cncr.30445 · Cited by 63
Self-citationMasselli, G., Tola, M. D., Casciani, E., Polettini, E., Laghi, F., Monti, R., Bernieri, M. G., & Gualdi, G. (2015) · Radiology · doi:10.1148/radiol.2015150263 · Cited by 62
Kim, J. E., Hong, Y. S., Kim, H. J., Kim, K., Lee, J., Park, S., Lim, S., Park, I. J., Kim, C. W., Yoon, Y. S., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4807-6 · Cited by 61
FDA approves larotrectinib for solid tumors with NTRK gene fusions
Administration, U. S. F. &. D. (2018) · Case Medical Research · doi:10.31525/fda1-ucm626720.htm · Cited by 60
Lifestyle factors and small intestine adenocarcinoma risk: A systematic review and meta-analysis
Bennett, C. M., Coleman, H. G., Veal, P., Cantwell, M. M., Lau, C. C. L., & Murray, L. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.02.001 · Cited by 58
Helical CT-enteroclysis in the detection of small-bowel tumours: a meta-analysis
Soyer, P. A., Aout, M., Hoeffel, C. C., Vicaut, É., Placé, V., & Boudiaf, M. (2012) · European Radiology · doi:10.1007/s00330-012-2595-y · Cited by 57
Genetic risks and familial associations of small bowel carcinoma
Shenoy, S. (2016) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v8.i6.509 · Cited by 55
Ecker, B. L., McMillan, M. T., Datta, J., Lee, M. K., IV, Karakousis, G. C., Vollmer, C. M., Drebin, J. A., Fraker, D. L., & Roses, R. E. (2016) · Cancer · doi:10.1002/cncr.30439 · Cited by 50
Gulhati, P., Raghav, K. P. S., Shroff, R. T., Varadhachary, G., Javle, M. M., Qiao, W., Wang, H., Morris, J. S., Wolff, R. A., & Overman, M. J. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0568 · Cited by 48
Self-citationIncidence, Management, and Course of Cancer in Patients with Inflammatory Bowel Disease
Algaba, A., Guerra, I., Marín‐Jiménez, I., Quintanilla, E., Serrano, P. L., García-Sánchez, M. C., Casís, B., Taxonera, C., Moral, I. C., Chaparro, M., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv032 · Cited by 46
Boffetta, P., Hazelton, W. D., Chen, Y., Sinha, R. R., Inoue, M., Gao, Y. T., Koh, W., Shu, X. O., Grant, E. J., Tsuji, I., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr562 · Cited by 44
Self-citationMcWilliams, R. R., Foster, N. R., Mahoney, M. R., Smyrk, T. C., Murray, J. A., Ames, M. M., Horvath, L. E., Schneider, D. J., Hobday, T. J., Jatoi, A., et al. (2017) · Cancer · doi:10.1002/cncr.30766 · Cited by 40
Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma
Ye, X., Zhang, G., Chen, H., & Li, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200204 · Cited by 38
Could the PD-1 Pathway Be a Potential Target for Treating Small Intestinal Adenocarcinoma?
Thota, R., González, R. S., Berlin, J. D., Cardin, D. B., & Shi, C. (2017) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqx070 · Cited by 33
Wright, P., Downing, A., Morris, E. J. A., Corner, J. L., Richards, M. A., Sebag‐Montefiore, D., Finan, P. J., & Glaser, A. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.6129 · Cited by 32
Takayoshi, K., Kusaba, H., Uenomachi, M., Mitsugi, K., Makiyama, C., Makiyama, A., Uchino, K., Shirakawa, T., Shibata, Y., Shinohara, Y., et al. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3371-0 · Cited by 30
Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma
Aydın, D., Şendur, M. A. N., Kefeli, U., Ustaalioglu, B. B., Aydin, Ö., Yıldırım, E., Işık, D., Özçelik, M., Sürmeli, H., Oyman, A., et al. (2016) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2016.04.013 · Cited by 27
Goverde, A., Korsse, S. E., Wagner, A., van Leerdam, M. E., Krak, N. C., Stoker, J., van Buuren, H. R., Hofstra, R. M. W., Bruno, M. J., Dewint, P., et al. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000592 · Cited by 24
Wilhelm, A., Müller, S., Steffen, T., Schmied, B. M., Beutner, U., & Warschkow, R. (2015) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-015-2994-x · Cited by 22
Management of duodenal adenomatosis in FAP: single centre experience
Drini, M., Speer, A. G., Dow, C. A., Collier, N. A., Bhathal, P. S., & Macrae, F. (2011) · Familial Cancer · doi:10.1007/s10689-011-9496-0 · Cited by 14
Familial Adenomatous Polyposis
Frayling, I. M. (2006) · Wiley eBooks · doi:10.1038/npg.els.0005966 · Cited by 11
Cited by
Woodhouse, R., Li, M., Hughes, J., Delfosse, D., Skoletsky, J., Ma, P., Meng, W., Dewal, N., Milbury, C., Clark, T., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0237802 · Cited by 516
Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review
Yang, J., Xu, R., Wang, C., Qiu, J., Ren, B., & You, L. (2021) · Cancer Communications · doi:10.1002/cac2.12204 · Cited by 379
Tap, W. D., Villalobos, V. M., Cote, G. M., Burris, H., Janku, F., Mir, O., Beeram, M., Wagner, A. J., Jiang, L., Wu, B., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02492 · Cited by 165
Johns, S. A., Tarver, W. L., Secinti, E., Mosher, C. E., Stutz, P. V., Carnahan, J. L., Talib, T. L., Shanahan, M. L., Faidley, M. T., Kidwell, K. M., et al. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103290 · Cited by 48
Metadata
- Authors
- Benson, A. B., Venook, A. P., Al-Hawary, M. M., Arain, M. A., Chen, Y.-J., Ciombor, K. K., Cohen, S. A., Cooper, H. S., Deming, D. A., Garrido-Laguna, I., Grem, J. L., Hoffe, S. E., Hubbard, J., Hunt, S., Kamel, A., Kirilcuk, N., Krishnamurthi, S., Messersmith, W. A., Meyerhardt, J., Miller, E. D., Mulcahy, M. F., Nurkin, S., Overman, M. J., Parikh, A., Patel, H., Pedersen, K. S., Saltz, L. B., Schneider, C., Shibata, D., Skibber, J. M., Sofocleous, C. T., Stoffel, E. M., Stotsky-Himelfarb, E., Willett, C. G., Johnson-Chilla, A., Gregory, K. M., & Gurski, L. A.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2019-09
- Volume
- 17
- Issue
- 9
- Pages
- 1109-1133
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W2971594300
- Cited by
- 269
- References
- 83
- FWCI
- 24.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.